KZR
NASDAQ · Biotechnology
Kezar Life Sciences Inc
$7.29
-0.07 (-0.95%)
Analyst Consensus
Hold
9
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+158.0% upside
Low Target
$12.87
Average Target
$18.81
High Target
$22.25
Current Price
$7.29
Current
$7.29
$7.29
Target
$18.81
$18.81
$12.87
$18.81 avg
$22.25
Scenario Analysis
Bear Case
$12.87
76.5%
Low target
Base Case
$18.81
+158.0%
Avg target
Bull Case
$22.25
+205.2%
High target
Risk/Reward
2.7x
Favorable
Price in Context
52-Week High
$7.55
-3.4% from high
52-Week Low
$5.98
+21.9% from low
Target vs 52W High
$18.81
+149.1% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.5% |
| AMGN | Hold | 42 | 43% | $190.87 | -59.0% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +115.4% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -18.5% |
| MRNA | Hold | 31 | 32% | $149.45 | -33.6% |
| REGN | Buy | 36 | 72% | $76.80 | -92.0% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -54.8% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -33.2% |